Although increasing representation of underserved populations in clinical trials has been a long-standing goal for industry, providers and patients alike, progress to date has been slow.
Americans are strongly focused on the upcoming midterm elections.
The Inflation Reduction Act of 2022 (IRA) includes the most dramatic change to U.S. drug price regulation in history.
In late June, California’s Governor Newsom signed the California Health Care Quality and Affordability Act, establishing a new Office of Health Care Affordability (OHCA) within the Department of Health Care Access and Information (HCAI).
The United States continues to face a behavioral health crisis that has worsened due to the COVID-19 pandemic. In 2021, nearly 40% of adults reported symptoms of depression or anxiety, an increase from 10% in 2019.
Last year, the number of overdose deaths in the United States exceeded 100,000 for the first time ever.
Mounting evidence indicates that addressing the social and economic factors that drive the majority of health outcomes, often called social drivers of health, can improve health, promote health equity and reduce costs.
Cost growth benchmarking programs allow states to see a complete picture of total health care spending in their markets, and pinpoint cost drivers.
By March of this year, more than 61% of Americans had experienced a telehealth visit—and almost 88% want to continue using telehealth for nonurgent consultations, even after the pandemic passes, according to findings reported in Healthcare Finance.
Drivers of Health (DOH)—the conditions under which people live, learn, work, play and age—are proven to have a greater impact on health than medical care.